Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Common Share (Tables)

6 Months Ended

Jun. 30, 2012


	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Numerator:
Net income (loss)—basic	$	17,001		$	(7,923	)	$	(98,532	)	$	(16,253	)
Less: noncash income from change in fair value of common stock warrants		(19,852	)		—			—			—

Net loss—diluted		(2,851	)		(7,923	)		(98,532	)		(16,253	)

Denominator:
Weighted average common shares outstanding		54,549			48,805			52,435			42,659
Dilutive effect of warrants		8,945			—			—			—

Weighted-average common shares outstanding and potential dilutive common shares—diluted		63,494			48,805			52,435			42,659

Net income (loss) per share
Basic	$	0.31		$	(0.16	)	$	(1.88	)	$	(0.38	)

Diluted	$	(0.04	)	$	(0.16	)	$	(1.88	)	$	(0.38	)


	Three Months Ended June 30,				Six Months Ended June 30,
	2012		2011		2012		2011
Shares issuable upon exercise of warrants		—		16,643		12,615		16,643
Shares issuable upon exercise of stock options		5,072		3,580		5,072		3,580
Shares issuable related to the ESPP		79		65		79		65